Always listen to your body, and remember that dose increases should only be made when necessaryif youre already seeing effective appetite suppression and weight loss, there's no need to push for higher doses
Difficulty Passing Stool: Straining, pushing, or spending a long time in the bathroom
Efficacy comparison by clinical trial data The most relevant head-to-head data comes from the SURPASS-2 trial (tirzepatide vs semaglutide 1 mg for type 2 diabetes) and the SURMOUNT-5 trial (tirzepatide vs semaglutide 2.4 mg for obesity)
If additional weight reduction is needed in patients with type 2 diabetes mellitus treated with WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection and follow the recommended dosage escalation for WEGOVY injection [see Dosage and Administration (2.2), Use in Specific Populations (8.6), Clinical Pharmacology (12.3)]
This fee covers a Nurx provider managing your medication needs
We will cover potential drug interactions, the risk of dehydration, and how to communicate with your healthcare provider about adjusting your schedule